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A mass spectrometric study has been carried out to elucidate the structures of glycated
peptides obtained after in vitro gastrointestinal digestion of bovine -lactoglobulin (-LG)
glycated with prebiotic galacto-oligosaccharides (GOS). The digests of both native and
glycated -LG were analyzed by MALDI-MS, LC-ESI-MS, and LC-ESI-MS/MS. MALDI-MS
profiles showed marked differences mainly related to the lower intensity of ions correspond-
ing to the digest of glycated -LG. Overall, 58 and 23 unglycated peptides covering 97% and
63% of the mature -LG sequence could be identified in the digests of native and glycated
samples, respectively. The LC-ESI-MS analyses corroborated the MALDI-MS results regarding
the unglycated peptides but they also enabled an extensive investigation into the digest of
glycated -LG. Thus, a total of 19 peptides glycated with GOS from two to seven hexose units
could be identified. The tandem mass spectra of glycated peptides were mostly characterized
by two neutral losses of 1026/1056, 864/894, 702/732, 540/570, 378/408, and 216/246 u,
corresponding to the formation of the furylium ion and its subsequent “CHOH” loss,
indicative of the peptide glycation with hepta-, hexa-, penta-, tetra-, tri-, and disaccharides,
respectively. Also, other minor ionic species containing the furylium ring linked to different
galactose units could be also detected, showing the diversity of the fragmentation pattern of
peptides glycated with larger size carbohydrates. Finally, the putative GOS glycation sites
could be determined at the NH2-terminal Leu residue and at Lys residues located in positions
14, 47, 75, 77, 83, 91, 100, 135, and 138. (J Am Soc Mass Spectrom 2008, 19, 927–937) © 2008
American Society for Mass SpectrometryThe Maillard reaction is one of the most importantand complex reactions between reducing sugarsand amino acids, peptides, or proteins that may
spontaneously occur in living organisms or during food
processing. Controversially, either beneficial or detri-
mental effects have been attributed to the Maillard
reaction products (MRP). Thus, some compounds such
as reductones and melanoidins have shown antioxidant
activity [1, 2], whereas the so-called “advanced glyca-
tion end products” (AGEs) include a variety of protein
adducts implicated in inflammatory reactions and tis-
sue damage [3, 4].
The resistance of some MRP to the gastrointestinal
digestion environment has been proven [5–7], indicat-
ing that they could be available for gut microflora
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doi:10.1016/j.jasms.2008.04.016fermentation. However, little is known about their
effects on the growth of these micro-organisms and
consequently on chronic gut disorders. Some studies
have revealed that t h e number of anaerobic species
increased following fermentation of melanoidins
produced from glucose and lysine [8]. Similarly,
Dell’Aquila et al. [9] demonstrated that melanoidins
derived from gluten glycated with glucose affect the
growth of the colonic microbiota. Tuohy et al. [10]
showed an increase of the more detrimental micro-
organisms against a diminution of the beneficial ones
(bifidobacteria and lactobacilli) following fermentation
of BSA glycated with glucose on fecal bacteria. How-
ever, to the best of our knowledge, no gut fermentation
studies have so far been performed using proteins
glycated with prebiotic carbohydrates (nondigestible
compounds, mainly carbohydrates, which selectively
stimulate the growth of certain intestinal bacteria ben-
eficially affecting host health [11]).
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leading to the development of persistent compounds,
which could achieve the hind gut where most of the
intestinal affections take place [12]. Considering that
Amadori compounds, the relatively stable products
formed during the early stages of the Maillard reaction,
can reach the distal regions of the gut [5–7], the conju-
gation between a prebiotic carbohydrate and a protein
could potentially allow carbohydrate to reach the distal
parts of the colon and be fermented slowly.
In a recent study, we reported the glycation of
bovine -lactoglobulin (-LG) with prebiotic carbohy-
drates, galacto-oligosaccharides (GOS), and its gastro-
intestinal digestion using a physiologically relevant in
vitro model system [13]. The results showed that -LG
can be efficiently glycated without substantial confor-
mational changes and that the -LG-GOS conjugates
could form stable glycated peptides surviving the in
vitro gastrointestinal digestion. Nevertheless, no fur-
ther identification of these potentially prebiotic pep-
tides was carried out.
The power of mass spectrometric techniques for the
study of glycated and nonglycated peptides has been
widely demonstrated [14, 15]. Matrix-assisted laser de-
sorption ionization (MALDI) and electrospray ioniza-
tion (ESI) have been used to determine the structure of
proteins and peptides and their glycation products with
monosaccharides [14, 16, 17]. In the case of -LG,
several articles describing the identification of lactose
and galactose glycation sites using different mass spec-
trometric strategies have been published in the last
decade [18–24]. However, none of these studies ad-
dressed the mass spectrometric characterization of the
peptide mapping resulting from the action of an in vitro
gastrointestinal digestion model which mimics the pas-
sage of the -LG into the stomach, and then, into the
gut. In this work, MS techniques (MALDI-MS, LC-
ESI-MS and LC-ESI-MS/MS) have been used to obtain
structural information of the glycated and unglycated
peptides derived from the gastric (pepsin) and duode-
nal (trypsin and chymotrypsin) digestion of -LG-GOS
Figure 1. Superimposed MALDI-MS spectra of undigested bo-
vine -LG native and glycated with GOS.conjugates and native -LG. The characterization of theglycated peptides is a requirement for understanding
their effects on the gut microbiota.
Experimental
Glycation of -LG with GOS
Preparation of galacto-oligosaccharides (GOS) and in
vitro glycation of -LG with GOS was carried out as
indicated by Sanz et al. [13]. Briefly, aliquots of a
solution consisting of 2.0 mg/mL -LG (mixture of A
and B variants) (Sigma, St. Louis, MO) and 2.0 mg/mL
GOS in 0.1 M sodium phosphate buffer, pH 7 (Merck,
Darmstadt, Germany), were lyophilized. These were
kept under vacuum in a desiccator at 40 °C for 16 days
and at water activity of 0.44, achieved with a saturated
K2CO3 solution (Merck). The original GOS source em-
ployed was a commercial product Vivinal-GOS, kindly
gifted by Borculo Domo (Hanzeplein, The Netherlands).
In Vitro Gastrointestinal Digestion
The native and glycated -LG were digested in vitro by
following the simplified procedure described by
Moreno et al. [25]. A 3 mg amount of protein was
dissolved in 1 mL of simulated gastric fluid (SGF; 0.15
M NaCl, pH 2.5) and the pH was adjusted to 2.5 with 1
M HCl. A solution of 0.32% (wt:vol) porcine pepsin (EC
3.4.23.1) in SGF, pH 2.5 (activity: 3300 U per mg of
protein; Sigma), was added at an approximately phys-
Figure 2. MALDI-MS spectra of in vitro gastrointestinal digests
of (a) unglycated -LG and (b) glycated -LG.
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Putative sequence assigned by using ExPASy
P02754 Position
Exp. Mass
[M  H]a
Theor. Mass
[M  H]a
Native
-LG
Glycated
-LG
LQKWENDbECAQKKLSFNPTQLEEQCHI or
QKWENDbECAQKKILSFNPTQLEEQCHI
58–70  149–162d or
59–71  149–162d
3275.5 3275.6 X
LQKWENGcECAQKKLSFNPTQLEEQCHI or
QKWENGcECAQKKILSFNPTQLEEQCHI
58–70  149–162d or
59–71  149–162d
3217.4 3217.6 X
QKWENDbECAQKKLSFNPTQLEEQCHI 59–70  149–162d 3162.4 3162.5 X
QKWENGcECAQKKLSFNPTQLEEQCHI 59–70  149–162d 3104.4 3104.5 X
KWENDbECAQKKLSFNPTQLEEQCHI 60–70  149–162d 3034.4 3034.4 X X
KWENGcECAQKKLSFNPTQLEEQCHI 60–70  149–162d 2976.3 2976.4 X X
WENDbECAQKKLSFNPTQLEEQCHI 61–70  149–162d 2906.3 2906.3 X X
WENGcECAQKKLSFNPTQLEEQCHI 61–70  149–162d 2848.2 2848.3 X X
ENDbECAQKKLSFNPTQLEEQCHI 62–70  149–162d 2720.2 2720.2 X X
ENGcECAQKKLSFNPTQLEEQCHI 62–70  149–162d 2662.2 2662.2 X
NKVLVLDTDYKKYLLFCMENSA 90–111 2607.1 2607.3 X X
LFCMENSAEPEQSLAcCQCLVR 104–124 (Internal S-S) 2369.0 2369.0 X
RVYVEELKPTPEGDLEILLQ 40–59 2341.2 2341.3 X X
ENGcECAQKKIIAEKTKIPAVF 62–82 2317.1 2317.3 X
VYVEELKPTPEGDLEILLQK 41–60 2313.3 2313.3 X
VEELKPTPEGDLEILLQKW 43–61 2237.2 2237.2 X X
YSLAMAASDISLLDAQSAPLR 20–40 2193.2 2193.1 X
VYVEELKPTPEGDLEILLQ 41–59 2185.2 2185.2 X
LRVYVEELKPTPEGDLEI or RVYVEELKPTPEGDLEIL 39–56 or 40–57 2100.1 2100.1 X X
VEELKPTPEGDLEILLQK 43–60 2051.1 2051.1 X X
VDDEALEKFDKALKALPM 128–145 2033.0 2033.1 X
YLLFCMENSAEPEQSLAc 102–118 1945.0 1944.9 X
VEELKPTPEGDLEILLQ 43–59 1923.0 1923.0 X X
VRTPEVDDEALEKFDK 123–138 1890.9 1890.9 X X
VEELKPTPEGDLEILL 43–58 1795.0 1795.0 X
VEELKPTPEGDLEIL 43–57 1681.9 1681.9 X
LSFNPTQLEEQCHI 149–162 1658.8 1658.8 X X
VRTPEVDDEALEKF 123–136 1647.8 1647.8 X X
TPEVDDEALEKFDK 125–138 1635.7 1635.8 X X
LSFNPTQLEEQCH 149–161 1545.7 1545.7 X X
VRTPEVDDEALEK 123–135 1500.7 1500.8 X X
TPEVDDEALEKF 125–136 1392.6 1392.7 X X
KWENDbECAQKK 60–70 1378.6 1378.6 X
VRTPEVDDEALE 123–134 1372.6 1372.7 X
VLVLDTDYKKY 92–102 1356.7 1356.7 X
KWENGcECAQKK 60–70 1320.6 1320.6 X
KIDALNENKVL 83–93 1256.7 1256.7 X
WENDbECAQKK 61–70 1250.5 1250.5 X
VEELKPTPEGD 43–53 1213.6 1213.6 X
WENGcECAQKK 61–70 1192.5 1192.5 X X
ENKVLVLDTD 89–98 1145.6 1145.6 X
LEKFDKALK 133–141 1091.5 1091.6 X X
ENDbECAQKK 62–70 1064.5 1064.5 X
ENGcECAQKK 62–70 1006.4 1006.5 X
VTQTMKGLD 3–11 992.3 992.5 X X
FNPTQLEE 151–158 977.5 977.5 X
ALPMHIRL 142–149 950.5 950.6 X X
LIVTQTMK 1–8 933.5 933.5 X
TKIPAVFK 76–83 903.5 903.6 X
LPMHIRL 143–149 879.5 879.5 X
DAQSAPLR 33–40 857.4 857.4 X
DKALKALP 137–144 855.0 855.5 X
VLDTDYK 94–100 853.4 853.5 X
ALPMHIR 142–148 837.5 837.5 X
GTWYSLA 17–23 797.4 797.4 X
TKIPAVF 76–82 775.4 775.5 X
PMHIRL 144–149 766.4 766.4 X
SLAMAASD or AMAASDIS 21–28 or 23–30 765.2 765.3 X X
aMonoisotopic mass values.
b-lactoglobulin genetic variant A.
c-lactoglobulin genetic variant B.
dPeptides containing two fragments linked by disulfide bond ().
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digestion was performed at 37 °C for 2 h.
For the intestinal digestion step, the pH was raised to
7.5 with 40 mM NH4CO3 (Panreac, Barcelona, Spain)
dropwise, and the following was added to adjust the pH
to 6.5 and simulate a duodenal environment: (1) a bile salt
mixture containing equimolar quantities (0.125 M) of
sodium taurocholate (Sigma) and glycodeoxycholic acid;
(Sigma); (2) 1MCaCl2 (Panreac); (3) 0.25M bis-tris; pH 6.5
(Sigma). Finally, solutions of porcine trypsin EC 3.4.21.4;
0.05%, wt:vol, type IX-S, activity: 14 300 U/mg of protein;
(Sigma), and bovine -chymotrypsin EC 3.4.21.1; 0.1%,
wt:vol, type I-S, activity: 62 U/mg of protein; (Sigma) in
water were prepared and added at approximately physi-
ological ratios of -LG:trypsin:chymotrypsin  1:(1/400):
(1/100) (wt:wt). Intestinal digestion of -LG was carried
out at 37 °C for 1 h. After protein hydrolysis, digestive
enzymes were inactivated by adding a solution of Bowman-
Birk trypsin-chymotrypsin inhibitor from soybean
(Sigma) at a concentration calculated to inhibit twice the
amount of trypsin and chymotrypsin present in the
digestion mix. Digestions were performed without any
derivatization of the sulfhydryl groups of cysteine
residues to remain as close as possible to physiological
Figure 3. Total ion current (TIC) chromatograms of in vitro
gastrointestinal digests of (a) unglycated -LG and (b) glycated
-LG.conditions.MS Analysis
MALDI-MS
MALDI-MS measurements were performed on a Voy-
ager DE-PRO mass spectrometer (Applied Biosys-
tems, Foster City, CA) equipped with a pulsed nitro-
gen laser (  337 nm, 3 ns pulse width, and 3 Hz
frequency) and a delayed extraction ion source. Ions
generated by laser desorption of both native and
glycated -LG were introduced into a time of flight
analyzer (1.3 m flight path) with an acceleration
voltage of 25 kV, 93% grid voltage, 0.05% ion guide
wire voltage, and a delay time of 350 ns in the linear
positive ion mode. Mass spectra were obtained over
the m/z range 10–35 ku. Apomyoglobin (Calibration
Mixture 3 of Sequazyme Peptide Mass Standards Kit;
Applied Biosystems) and carbonic anhydrase (Sigma)
were used for external mass calibration. Sinapinic
acid (99%; Fluka, Buchs, Switzerland) at 10 mg
mL1 in TFA 0.3%:acetonitrile 70:30 (vol/vol) was
used as matrix. Samples were mixed with the matrix
at a ratio of 1:15 (vol/vol), and 1 L of this solution
was spotted onto a flat stainless-steel sample plate
and dried in air.
Digestion mixtures of both proteins were analyzed
in the same spectrometer but operating in the reflec-
tor mode at the following conditions: acceleration
voltage, 20 kV; grid voltage, 74%; ion guide wire
voltage, 0.001%; and delay time, 300 ns. Mass spectra
were acquired in the positive ion mode, scanning
from m/z 750 to m/z 4500. External mass calibration
was applied using the monoisotopic [M  H] values
of des-Arg1 bradykinin, angiotensin I, ACTH (1-17
clip), ACTH (18–39 clip), and ACTH (7–38 clip) of the
Calibration Mixture 2, Sequazyme Peptide Mass Stan-
dards Kit; Applied Biosystems. -Cyano-4-hydroxy-
cinnamic acid (99%, Fluka) at 10 mg mL1 in TFA
0.3%:acetonitrile 50:50 (vol/vol) was used as matrix.
Digestion mixtures of native and glycated -LG were
dilute with water 10 and 5 times, respectively, and
mixed with the matrix at a ratio of 1:4 (vol/vol). One
L of this solution was spotted onto a flat stainless-
steel sample plate and dried in air before analysis.
LC-ESI-MS
LC-MS and LC-MS/MS experiments were carried out on
a Finnigan Surveyor pump with quaternary gradient
system coupled to a Finnigan LCQ Deca ion trap mass
spectrometer using an ESI interface. Sample injections
(5 L) were carried out by a Finnigan Surveyor au-
tosampler. All instruments from Thermo Fisher Scientific
(San Jose, CA), formic acid of analytical grade (Merck,
Darmstadt, Germany), andMilli-Qwater obtained using a
Millipore, Bedford, MA system were used.
The digestion mixtures of both glycated and ungly-
cated -LG were diluted 1:2 with water, and their
separation performed at 25 °C on a Hypersil HyPurity
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Scientific) at a flow rate of 100 L min1. A gradient of
two eluents was used: eluent A consisted in 0.1%
(vol/vol) of formic acid (analytical grade; Merck, Darm-
stadt, Germany) in water, and eluent B in acetonitrile
(LC-MS Chromasolv grade; Riedel-de Haën, Seelz, Ger-
many) containing 0.1% of formic acid (vol/vol). The
elution program was applied as follows: at the start 5%
Table 2. Unglycated peptides identified in the digests of native
RT (min)
Putative sequence assigned
by using ExPASy P02754 Position
3.9 IIAEK 71–75
3.9 KIDALNENK 83–91
4.2 VLDTDYK 94–100
4.6 KIDALN 83–88
5.0 KIDALNE 83–89
5.8 KALPM 141–145
6.3 KIIAEK 70–75
7.6 LKPTPEGDL 46–54
8.2 LIVTQTMK 1–8
11.2 VLVLDTDYK 92–100
12.2 TPEVDDEALE 125–134
12.9 VEELKPTPEGDLE 43–55
14.9 VRTPEVDDEALE 123–134
16.0 ALPMHIR 142–148
16.6 VEELKPTPEGDL 43–54
17.0 EALEKF 131–136
17.2 WENGcECAQKK 61–70
17.6 LIVTQTM 1–7
18.8 KIDALNENKVL 83–93
19.3 VAGTWY 15–20
20.2 TPEVDDEALEKFDK 125–138
20.6 VRTPEVDDEALEKFDK 123–138
21.1 SFNPTQL 150–156
22.0 TKIPAVF 76–82
22.5 VRTPEVDDEALEKF 123–136
22.6 TPEVDDEALEKF 125–136
23.6 IPAVF 78–82
24.2 VLVLDTDY 92–99
25.6 LFCMENSAEPEQSLAcCQCLVR 104–124 (interna
26.3 VAGTWYS or CMENSAE 15–21 or 106–1
26.9 KWENGcECAQKK 60–70
27.3 MAASDISLL 24–32
27.5 VEELKPTPEGDLEIL 43–57
27.9 AMAASDISLL 23–32
29.4 VEELKPTPEGDLEILLQK 43–60
29.4 VYVEELKPTPEGDLEIL 41–57
30.4 VYVEELKPTPEGDLEILLQK 41–60
30.8 RVYVEELKPTPEGDLEILLQ 40–59
31.5 VEELKPTPEGDLEILLQ 43–59
32.2 SLAMAASDISLL 21–32
32.5 YLLF 102–105
32.9 VYVEELKPTPEGDLEILLQ 41–59
34.0 KGLDIQKVAGTW 8–19
35.6 YSLAMAASDISLL 20–32
36.5 VDDEALEKFDKALKALPM 128–145
36.6 VEELKPTPEGDLEILLQKW 43–61
37.2 WENDbECAQKK 61–70
aMonoisotopic mass values.
b-Lactoglobulin genetic variant A.
c-Lactoglobulin genetic variant B.B; after 5 min the percentage of B was linearly increasedto 50% in 50 min; 50% to 90% B linear from 55 to 57 min;
90% B isocratic from 57 to 70 min; ramped to original
composition in 1 min, then equilibrated for 15 min.
The mass spectrometer spray voltage was set at 4.5
kV, heated capillary temperature at 200 °C, nitrogen
(99.5% purity) was used as sheath (0.6 L min1) and
auxiliary (6 L min1) gas, and helium (99.999% purity)
as the collision gas. Mass spectra were recorded in the
glycated -LG by LC-ESI-MS
Exp. mass
[M  H]a
Theor. mass
[M  H]a
Main
charge
state
Native
-LG
Glycated
-LG
573.3 573.4 1 X X
1044.6 1044.6 1 X
853.4 853.5 1 X X
673.3 673.4 1 X X
802.4 802.4 1 X X
559.2 559.3 1 X X
701.2 701.5 1 X X
969.4 969.5 2 X X
933.5 933.5 2 X
1065.4 1065.6 2 X X
1117.4 1117.5 1 X X
1455.6 1455.7 2 X
1372.6 1372.7 2 X X
837.5 837.5 1 X
1326.6 1326.7 2 X X
736.3 736.4 1 X
1192.4 1192.5 1 X X
805.3 805.4 1 X X
1256.7 1256.7 2 X X
696.2 696.3 1 X X
1635.7 1635.8 2 X X
1890.9 1890.9 2 X X
806.3 806.4 1 X X
775.4 775.5 1 X X
1647.8 1647.8 2 X X
1392.6 1392.7 2 X X
546.3 546.3 1 X X
937.4 937.5 1 X
) 2369.0 2369.0 3 X
783.1 783.4 or 783.3 1 X
1320.4 1320.6 1 X
920.3 920.5 1 X
1681.9 1681.9 2 X X
991.4 991.5 1 X X
2050.9 2051.1 3 X X
1943.7 1944.0 2 X X
2313.3 2313.3 3 X
2341.2 2341.3 3 X
1923.0 1923.0 2 X X
1191.5 1191.6 1 X X
555.2 555.3 1 X X
2185.0 2185.2 2 X X
1316.1 1315.7 1 X X
1354.5 1354.7 1 X X
2033.0 2033.1 2 X
2237.2 2237.2 3 X X
1250.7 1250.5 1 Xand
l S-S
12positive ion mode. MS/MS data were acquired in the
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Data Treatment
MALDI-MS data were evaluated by the Data Explorer
program (Voyager 5.1 Software with Data Explorer;
Applied Biosystems). The LC-MS system, data acquisi-
tion and processing were managed by Xcalibur soft-
ware, (1.2 version; Thermo Fisher Scientific).
The assignment of observed ions to the correspond-
ing amino acid sequences was based on the known
sequence of -LG [26] by using the protein database
Swiss-Prot and TrEMBL and the tools Peptide Mass and
FindPept available at www.expasy.org. Parameters for
the search were the following: (1) Monoisotopic peptide
masses were indicated as [M  H] with cysteines
treated with nothing; (2) as enzymes, pepsin, and
trypsin/chymotrypsin were chosen; (3) four missed
cleavages were allowed; (4) peptides with a mass larger
than 500 u were displayed; (5) the mass tolerance was
kept at 0.5 u.
All full scan MS/MS spectral data were searched
using the Bioworks version 3.1 suite of programs
Figure 4. ESI mass spectra of doubly charged ions corresponding
to (a) unglycated and (b) glycated 43V-Q59 peptide.(Thermo Fisher Scientific). A precursor mass toleranceof 1.4 u was used to search the resulting DTA files
against computer-predicted fragments. All Bioworks
3.1 output files were further filtered according to cross-
correlation (Xcorr) scores as a function of charge states
to increase confidence limits. Specifically, the Xcorr
cutoff values used to determine acceptable peptide
matches were 1.5 for digest fragments originating from
precursor ions with a charge state of one, 2.0 for digest
fragments originating from doubly charged precursor
ions, and 2.5 for triply charged ions.
Results and Discussion
Determination of the Extent of Glycation
The MALDI-MS analysis of undigested -LG stored
with GOS for 16 days demonstrated that this protein
can be glycated through the Maillard reaction to a
considerable and variable degree (Figure 1). Either the
presence of two -LG genetic variants with multiple
glycation sites (15 Lys, 3 Arg, and the NH2-terminal Leu
residues) or the use of GOS with different degrees of
polymerization (from 2 to 7) explain the great variety of
individual glycated protein species obtained after stor-
age. Thus, the mass spectrum of the native -LG was
000200510001005
m/z
R
el
at
iv
e 
A
bu
nd
an
ce
746.7
1119.5
747.4
962.7
1016.9
908.5
854.3
0
10
20
30
40
50
60
70
80
90
100
0
10
20
30
40
50
60
70
80
90
100
[M+3H]3+
[M+2H]2+
[M+3H+Disac]3+
[M+3H+Trisac]3+
[M+3H+Tetrasac]3+
[M+3H+Pentasac]3+
43VEELKPTPEGDLEILLQKW61
[Unglycated]
43VEELKPTPEGDLEILLQKW61
[Glycated]
(a)
(b)
Figure 5. ESI mass spectra of triply charged ions corresponding
to (a) unglycated and (b) glycated 43V-W61 peptide.
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RT (min)
Putative sequence assigned
by using ExPASy P02754 Position
Exp. mass
[M  H]a
Theor. mass
[M  H]a
Main charge
state D.P. GOS
4.0–4.1 IIAEK* 71–75 1059.6 1059.4 1 3
1221.5 1221.4 4
4.1 ENK*VLVLDTD 89–98 1955.5 1955.6 2 5
4.2 K*IDALNE 83–89 1450.4 1450.4 1 4
4.5–4.6 FDK*ALK 136–141 1207.5 1207.4 2 3
1369.8 1369.4 4
8.2–9.2 LK*PTPEGDL 46–54 1293.9 1293.5 2 2
1455.9 1455.5 3
1617.9 1617.5 4
1779.7 1779.5 5
12.7–13.3 TK*IPAVFK 76–83 1389.4 1389.6 1 3
1551.5 1551.6 4
1713.9 1713.6 5
1875.5 1875.6 6
2037.9 2037.6 7
14.4–16.2 VEELK*PTPEGDL 43–54 1650.5 1650.7 2 2
1813.1 1812.7 3
1974.7 1974.7 4
2136.9 2136.7 5
15.4 L*IVTQTM 1–7 1129.3 1129.4 1 2
17.0–18.0 K*IDALNENK*VL 83–93 1581.4 1580.7 2 2
1743.4 1742.7 3
1905.2 1904.7 4
2067.4 2066.7 5
2229.4 2228.7 6
19.0–20.0 VLVLDTDYK*K 92–101 1841.5 1841.7 2 4
2003.5 2003.7 5
2165.5 2165.7 6
20.7–21.5 TK*IPAVF 76–82 1261.5 1261.5 2 3
1423.8 1423.5 4
1585.9 1585.5 5
20.6–21.4 TPEVDDEALEK*F 125–136 1879.0 1878.7 2 3
2041.4 2040.7 4
2203.0 2202.7 5
25.1–25.9 VEELK*PTPEGDLEIL 43–57 2168.0 2167.9 2 3
2330.0 2329.9 4
2492.0 2491.9 5
2654.0 2653.9 6
25.3 VRTPEVDDEALEK*FDK*AL 123–140 2723.4 2723.1 3 4
25.1–26.0 TPEVDDEALEK*FDK*AL 125–140 2306.9 2305.9 3 3
2468.4 2467.9 4
2630.4 2629.9 5
25.0–26.6 GLDIQK*VAGTWY 9–20 1836.8 1836.7 2 3
1998.8 1998.7 4
2160.5 2160.7 5
2323.0 2322.7 6
28.0–28.9 VEELK*PTPEGDLEILLQK 43–60 2375.6 2375.1 3 2
2537.5 2537.1 3
2699.3 2699.1 4
2861.4 2861.1 5
30.0–30.9 VEELK*PTPEGDLEILLQ 43–59 2247.0 2247.0 2 2
2410.0 2409.0 3
2571.2 2571.0 4
2732.8 2733.0 5
2895.6 2895.0 6
34.9–35.9 VEELK*PTPEGDLEILLQK*W 43–61 2561.5 2561.2 3 2
2723.5 2723.2 3
2885.6 2885.2 4
3047.2 3047.2 5aMonoisotopic mass values.
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and 18,363 u corresponding to the theoretical masses of
the variants B and A, respectively. Other minor masses
attributed mainly to some matrix-adducts were also
detected in the native -LG mass spectrum (Figure 1).
However, a Gaussian distribution of masses over the
range of approximately m/z 19,000 to 25,000 u was
detected for the glycated -LG. The Gaussian peak
showed a maximum of intensity at 21,700 u, indicat-
ing an increase of 19% in the molecular mass of the
-LG sequence (Figure 1).
Identification of -LG Peptides Resulting from the
In Vitro Gastrointestinal Digestion
Both native and glycated -LG were subjected to a
Scheme 1. Proposed dissociation pathway for peptides glycated
with galacto-oligosaccharides of degree of polymerization  2
following ESI-MS/MS analysis.pepsin digestion; then they were hydrolyzed by trypsinand chymotrypsin simulating a duodenal environment.
As expected, both proteins were very resistant to pep-
sinolysis (data not shown) because -LG is a poor
substrate for pepsin [27–30]. Nevertheless, the duodenal
digestion (trypsin and chymotrypsin) of the native and
glycated -LG gave rise to a very complex mixture of
peptides after 1 h of incubation as was previously
observed by reversed-phase LC-UV [13]. The difference
in amino acid specificity of these two enzymes may
contribute to the release of a great number of peptides.
Trypsin cleaves on the C-side of basic residues (Arg and
Lys) whilst chymotrypsin requires an aromatic or bulky
nonpolar side-chain (Phe, Tyr, Trp, Leu, Met) on the
Figure 6. MS/MS spectra of single charged ion corresponding to
(a) glycated 83K-E89 peptide, and doubly charged ions correspond-
ing to (b) glycated 89E-D98 peptide, and (c) glycated 136F-K141peptide.
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studies demonstrated that -LG can be hydrolyzed to a
large extent following a trypsin/chymotrypsin diges-
tion [30, 32, 33]. To determine the complex peptide
mapping of both digestion mixtures, MALDI-MS and
LC-ESI-MS analyses were carried out.
MALDI-MS Analysis
Figure 2 shows the MALDI-MS profiles of both digested
native and glycated -LG. Although a large number of
ions remained present in both samples, most of those
present in the glycated -LG were much less abundant.
This fact could be attributed to a sum of multiple facts
such as the lower ionization power of glycated peptides,
the lower susceptibility to digestion for glycated proteins
[14, 34], or the partial glycation of Lys-containing and/or
N-terminal peptides. Overall, 58 and 23 peptides cov-
ering 97% and 63% of the mature -LG sequence could
be identified by MALDI-MS in the digests of native and
glycated samples, respectively (Table 1).
The peptides released at higher intensities from
native -LG were identified as fragments (by decreas-
ing order of abundance): 123Val-Phe136 (m/z 1647.8),
123Val-Lys138 (m/z 1891.9), 43Val-Gln59 (m/z 1924.0), and
43Val-Trp61 (m/z 2238.2) (Figure 2a). The peptide 123Val-
Lys138 was obtained as a result of a combination of
chymotryptic and tryptic cleavages occurring at bonds
122Leu-Val123 and 138Lys-Ala139, respectively. Then, this
peptide was again cleaved by chymotrypsin at the bond
136Phe-Asp137 to eventually release the fragment 123Val-
Phe136. Additionally, the peptides 43Val-Gln59 and
43Val-Trp61 are probably derived exclusively from the
chymotrypsin action by cleaving the bonds 42Tyr-Val43,
61Trp-Glu62, and 59Gln-Lys60. Chicon et al. [35], who
also observed the peptides 43Val-Gln59 and 43Val-Trp61
following chymotrypsin digestion of native -LG, indi-
cated that Gln residues can be also cleaved by chymo-
trypsin, particularly when followed in the sequence by
Lys, Arg, Ser, or Thr.
The MALDI spectrum of the digested glycated -LG
was dominated by signals at m/z 1091.5, 1545.6, and
1647.8, which could correspond to the unglycated pep-
tides 133Leu-Lys141, 149Leu-His161 and 123Val-Phe136, re-
spectively (Figure 2b). On the other hand, taking into
consideration that the glycated Lys residues are not
cleaved by trypsin [18, 36], the tentative disappearance
of the assigned peptides 1Leu-Lys8, 20Tyr-Arg40, 33Asp-
Arg40, 41Val-Lys60, 59Gln-Lys70  149Leu-Ile162, 60Lys-
Lys70, 62Glu-Lys70, 76Thr-Lys83, 94Val-Lys100, 104Leu-
Arg124 and 142Ala-Arg148 after glycation, could suggest
that the Lys residues located at the positions 8, 60, 70,
83, and 100, and the Arg residues at positions 40, 124,
and 148 are occupied by GOS (Table 1). However, the
rest of Lys or Arg residues cannot be ruled out as
potential glycation sites because many unglycated pep-
tides were still detected, indicating that glycation was
substoichiometric and, therefore, it is very plausible to
detect the same peptide in its glycated and unglycatedform [37]. Finally, nine new ionic species of low abun-
dances were detected at m/z values of 1756.8, 1567.6,
1113.5, 1097.5, 1059.4, 982.3, 976.3, 930.4, and 758.3.
These mass values might correspond either to glycated
short peptides or to unglycated peptides generated by
new enzymatic cleavages as glycation may modify
enzyme action [14].
LC-ESI-MS Analysis
Figure 3 illustrates the resulting total ion current (TIC)
chromatogram for glycated and unglycated digested
proteins. Due to the complexity of the peptides profile
and to the incomplete chromatographic separation be-
tween nonglycated and glycated peptides, analogous
digestion patterns were apparently obtained for ungly-
cated and glycated -LG [13, 19]. A similar behavior
was observed for other proteins such as bovine serum
albumin (BSA) [34] or HSA [14, 38]. In good agreement
with this, 33 of the 47 unglycated peptides identified in
the digest of native -LG were also detected in that of
glycated -LG (Table 2). Around 91% and 77% of the
-LG sequence were covered by the peptides identified
by LC-ESI-MS in the digests of the native and glycated
protein, respectively.
However, some minor differences such as the disap-
pearance of some peaks or the formation of peak
shoulders were found between both TIC profiles, sug-
gesting the presence of glycated peptides. Furthermore,
the LC-ESI-MS analysis of the digest of glycated -LG
showed numerous spectra dominated by series of dou-
bly or triply charged ions differing by 81 or 54 u,
respectively. This indicated that these spectra were
characterized by the presence of the same peptide
glycated with GOS of different degrees of polymeriza-
tion, explaining the accumulated difference in one unit
of galactose (162 u). As examples, Figures 4 and 5 show
the electrospray mass spectra of the peptides 43Val-
Gln59 and 43Val-Trp61 either in their unglycated or
glycated (with GOS ranging from 2 to 6 units of
galactose) form. Table 3 summarizes the 19 peptides
glycated with GOS of different degrees of polymeriza-
tion (from 2 to 7) identified by LC-ESI-MS. Glycated
peptides had shorter retention times in the reversed-
phase column than their unglycated forms (Tables 2
and 3) due to that the incorporation of GOS residues
into the peptide chain leads to an increase in peptide
hydrophilicity.
Overall, from these results can be inferred that Lys
residues located at positions 14, 47, 75, 77, 83, 91, 100,
135, and 138, as well as the NH2-terminal Leu residue,
are GOS glycation-sites. Morgan et al. [22] and Fenaille
et al. [24] observed that Lys residues at 47 and 91 were
the first modified sites following dry-state lactosylation
of bovine -LG, although the rest of Lys residues were
also glycated when longer incubation times were car-
ried out.
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LC-ESI-MS/MS analyses were performed to confirm
the structure of those peptides which showed the high-
est relative abundances by MALDI-MS and LC-ESI-MS.
Marked differences in the fragmentation behavior be-
tween glycated and unglycated peptides were found.
Thus, the unglycated peptides produced a MS/MS
spectrum in which the typical y- and b-series predom-
inate (data not shown). The 22 unglycated peptides
identified by tandem MS were located at the NH2
terminus and at the regions spanning the residues
20–32, 40–61, 71–100, and 123–138. Without reduction,
no peptides containing cysteine residues were assigned,
suggesting that all cysteines in -LG could be partici-
pating in disulfide bridges.
The tandem mass spectra of the glycated peptides
identified by LC-ESI-MS (Table 3) were mainly charac-
terized by the formation of the furylium ion and its
subsequent CHOH loss. Other minor ionic species
containing the furylium ring linked to galactose units
could be also detected, pointing out the diversity of the
fragmentation pattern of peptides glycated with larger
size carbohydrates. As an example, Scheme 1 illustrates
a possible fragmentation pathway of a peptide glycated
with a tetrasaccharide compatible with the main ions
detected by MS/MS. Mollé et al. [21] and Jeric et al. [39]
described the pathways for the formation of the fury-
lium ion and its CHOH loss from Amadori rearrange-
ment products involving di- and monosaccharides
linked to a peptidic chain, respectively. The data re-
ported in our study demonstrate that these ionic species
are also formed following ESI-MS/MS analysis of pep-
tides glycated with carbohydrates of higher molecular
weight. Thus, the losses of 1026/1056, 864/894, 702/
732, 540/570, 378/408, and 216/246 u were indicative of
the peptide glycation with hepta-, hexa-, penta-, tetra-,
tri-, and disaccharides, respectively. Considering the
presence of doubly and triply charged glycated pep-
tides, these mass values were also divided by 2 and 3 to
scan for constant formal neutral losses. Figure 6a and b
show the MS/MS spectra of the peptides 83Lys-Glu89
and 89Glu-Asp98 glycated with GOS of 4 and 5 hexose
units, respectively. Strikingly, MS/MS spectra of two
glycated peptides, 136Phe-Lys141 (Figure 6c) and 43Val-
Glyn59 (spectrum not shown), were dominated by sin-
gly and doubly charged ions derived exclusively from
losses of galactose units (Figure 6c).
Conclusions
In general terms, a good correlation between the mo-
lecular masses obtained for the unglycated peptides by
ESI-MS and MALDI-MS was obtained, although pep-
tides with low masses (800 u) were mainly identified
by LC-ESI-MS, whereas those with mass values be-
tween 2300 and 3000 u were detected by MALDI-MS.
On the contrary, substantial differences between both
MS techniques were observed for the detection of theglycated peptides, where LC-ESI-MS showed to be a
more effective technique than MALDI-MS.
Further ESI-MS/MS analyses corroborated the LC-
ESI-MS results and also enabled an extensive investiga-
tion into the glycated peptides produced by the in vitro
gastrointestinal digestion. Thus, the formation of the
characteristic furylium ion and its CHOH loss allowed
the detection of a number of peptides glycated with
GOS of different degrees of polymerization (from 2 to
7). Consequently, the putative GOS glycation sites were
located at the NH2-terminal Leu residue and at the Lys
residues 14, 47, 75, 77, 83, 91, 100, 135, and 138. The
structural characterization of the glycated peptides sur-
viving the in vitro gastrointestinal digestion of -LG
described in this work is important for future studies
investigating the effect of these peptides on the gut
microbiota.
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